Skip to main content
Fig. 4 | Biomarker Research

Fig. 4

From: Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

Fig. 4

Retrospective cohort combining TIGS and cell proliferation to determine ORR to ICI (A), and survival (B). A. Clinical ORR for each subgroup in the retrospective cohort when TIGS is used in conjunction with cell proliferation score classification. B. Kaplan Meier survival curves of combined TIGS and cell proliferation status for 242 ICI treated retrospective cohort

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us